Treatment of Refractory Convulsive Status Epilepticus in Children: Other Therapies

Seminars in Pediatric Neurology

Volumn 17, Issue 3, 2010, Pages 190-194

  Wheless, James W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CORTICOSTEROID; CORTICOTROPIN; DESFLURANE; DIAZEPAM; HALOTHANE; IMMUNOGLOBULIN; ISOFLURANE; MIDAZOLAM; PENTOBARBITAL; PROPOFOL;

CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; CONVULSIVE STATUS EPILEPTICUS; DOSE RESPONSE; DRUG CHOICE; DRUG DOSE TITRATION; DRUG MONITORING; DRUG WITHDRAWAL; EPILEPSY; HUMAN; HYPOTENSION; IMMUNOMODULATION; INDUCED HYPOTHERMIA; INFANTILE SPASM; INTENSIVE CARE; INTRACTABLE EPILEPSY; KETOGENIC DIET; LENNOX GASTAUT SYNDROME; LOW DRUG DOSE; NEUROMODULATION; NEUROSURGERY; NONHUMAN; OUTCOME ASSESSMENT; PLASMAPHERESIS; REVIEW; TREATMENT RESPONSE;

EID: 77955801076     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.06.007     Document Type: Review

References (44)

1. Owens J. Medical management of refractory status epilepticus in children. Seminars in Pediatr Neurol 2010.
2. Vendrame M., Loddenkemper T. Surgical treatment of refractory status epilepticus in children: Candidate selection and outcome. Semin Pediatr Neurol 2010.
3. Wusthoff C.J., Kranick S.M., Morley J.F., et al. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia Oct 20 2009, (Epub).
4. Kumada T., Miyajima T., Kimura N., et al. Modified Atkins diet for the treatment of nonconclusive status epilepticus in children. J Child Neurol 2010, 25:485-489.
5. Wheless J.W. The ketogenic diet. Pediatric Neurology: Principles and Practice 2006, CV Mosby, Co, Philadelphia. (ed 4). K.F. Swaiman, S. Ashwal, D.M. Ferriero (Eds.).
6. Kossoff E.H., Zupec-Kania B.A., Amark P.E., et al. Optimal clinical management of children receiving the ketogenic diet recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009, 50:304-317.
7. Baumeister F.A., Oberhoffer R., Liebhaber G.M., et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004, 35:250-252.
8. Robakis T.K., Hirsch L.J. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006, 4:35-46.
9. McDaneld L.M., Fields J.D., Bourdette D.N., et al. Immunomodulatory therapies in neurologic critical care. Neurocrit Care 2010, 12:132-143.
10. Verhelst H., Boon P., Buyse G., et al. Steroids in intractable childhood epilepsy clinical experience and review of the literature. Seizure 2005, 14:412-421.
11. Okumura A., Tsuji T., Kato T., et al. ACTH therapy for generalized seizures other than spasms. Seizure 2006, 15:469-475.
12. van Rijekevorsel-Harmant K., Delire M., Schmitz-Moorman W., et al. Treatment of refractory epilepsy with intravenous immunoglobulins: Results of the first double blind/dose finding clinical study. Int J Clin Lab Res 1994, 24:162-166.
13. B receptor in limbic encephalitis with seizures: Case series and characterization of the antigen. Lancet Neurol 2010, 9:67-76.
14. Dalmau J. Status epilepticus due to paraneoplastic and non paraneoplastic encephalitides. Epilepsia 2009, 50:58-60.
15. Dalmau J., Gleichmon A.J., Hughes E.G., et al. Anti-NMDA receptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
16. Ferlazzo E., Raffaele M., Mazzu I., et al. Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy. Epilepsy Behav 2006, 8:328-330.
17. Andrews P.I., Dichter M.A., Berkovic S.F., et al. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996, 46:242-246.
18. Hart Y.M., Cortez M., Andermann F., et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): Effects of high-dose steroids or immunoglobulins in 19 patients. Neurologist 1994, 44:1030-1036.
19. Prasad A.N., Stafstrom C.F., Holmes G.L. Alternative epilepsy therapies: The ketogenic diet, immunoglobulins, and steroids. Epilepsia 1996, 37(suppl 1):S81-S95.
20. Liu Z., Gatt A., Mikati M., et al. Effect of temperature on kainic acid-induced seizures. Brain Res 1993, 631:51-58.
21. Lundgren J., Smith M.-L., Blennow G., et al. Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage. Exp Brain Res 1994, 99:43-55.
22. Schmitt F.C., Buchheim K., Meierkord H., et al. Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis 2006, 23:689-696.
23. Hrncic D., Vacevic D., Rasic A., et al. Moderate body hypothermia alleviates behavioral and EEG manifestations of audiogenic seizures in metaphit-treated rats. Can J Physiol Pharmacol 2007, 85:1032-1037.
24. Sourek K., Tranicek V. General and local hypothermia of the brain in the treatment of intractable epilepsy. J Neurosurg 1970, 33:253-259.
25. Quasha A.L., Tinker J.H., Sharbrough F.W. Hypothermia plus thiopental. Anesthesiology 1981, 55:636-640.
26. Orlowski J.P., Erenberg G., Lueders H., et al. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984, 12:367-372.
27. Corry J.J., Dhar R., Murphy T., et al. Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9:189-197.
28. Shorvon S., Baulac M., Cross H., et al. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London colloquium on status epilepticus. Epilepsia 2008, 49:1277-1285.
29. Tortorici M.A., Kochanek P.M., Poloyac S.M. Effects of hypothermia on drug disposition, metabolism, and response: A focus oh hypothermia-mediated alterations on the cytochrome P450 emzyme system. Crit Care Med 2007, 35:2196-2204.
30. Filippi L., laMarca G., Fiorini P., et al. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia 2009, 50:2355-2361.
31. Delgado-Escueta A.V., Wasterlain C., Treiman D.M., et al. Management of status epilepticus. N Engl J Med 1982, 306:1337-1340.
32. Cruse R.P. Treatment of status epilepticus. Cleve Clin J Med 1988, 56(suppl 2):S254-S259.
33. Tunik M.G., Young G.M. Status epilepticus in children: The acute management. Pediatr Clin North Am 1992, 39:1007-1030.
34. Muran K., Shingu K., Tsushima K., et al. The anticonvulsant effects of volatile anesthetics on penicillin-induced status epilepticus in cats. Anesth Analg 2000, 90:142-147.
35. Muran K., Shingu K., Miyamoto E., et al. Anticonvulsant effects of sevoflurane on amygdaloid kindling and bicuculline-induced seizures in cats: Comparison with isoflurane and halothane. J Anesth 2002, 16:34-43.
36. Kokfe W.A., Snider M.T., Young R.S.K., et al. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology 1985, 62:653-656.
37. Ropper A.H., Kofke A., Bromfield E.B., et al. Comparison of isoflurane, halothane and nitrous oxide in status epilepticus. Ann Neurol 1986, 19:98-99.
38. Kofke W.A., Young R.S.K., Davis P., et al. Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology 1989, 71:653-659.
39. Meeke R.I., Soifer B.E., Gelb A.W. Isoflurane for the management of status epilepticus. Ann Pharmacother 1989, 23:579-581.
40. Hilz M.J., Bauer J., Claus D., et al. Isoflurane anesthesia in the treatment of convulsive status epilepticus. J Neurol 1992, 239:135-137.
41. Sharpe M.D., Young G.B., Mirsattari S., et al. Prolonged desflurane administration for refractory status epilepticus. Anesthesiology 2002, 97:261-264.
42. Mirsattari S.M., Sharpe M.D., Young G.B. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004, 61:1254-1259.
43. Minicucci F., Muscas G., Perucca E., et al. Treatment of status epilepticus in adults: Guidelines of the Italian league against epilepsy. Epilepsia 2006, 47(suppl 5):9-15.
44. Tobias J.D. Therapeutic applications and uses of inhalational anesthesia in the pediatric intensive care unit. Pediatr Crit Care Med 2008, 9:169-179.